Glycemic control in youth with type 2 diabetes

New England Journal of Medicine

Volumn 367, Issue 11, 2012, Pages 1066-1067

  Krishnan, Nithya ^a   Krishnan, Ramiah ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 1ALPHA; METFORMIN; NATEGLINIDE; ROSIGLITAZONE; SULFONYLUREA;

DRUG TREATMENT FAILURE; GENETIC SCREENING; GLYCEMIC CONTROL; HUMAN; JUVENILE DIABETES MELLITUS; LETTER; MATURITY ONSET DIABETES MELLITUS; MONOGENIC DISORDER; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL;

EID: 84866114606     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1208408     Document Type: Letter

References (5)

1. TODAY Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 2012;366:2247-56.
2. American Diabetic Association. Type 2 diabetes in children and adolescents. Diabetes Care 2000;23:381-9.
3. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT. Genetic cause of hyperglycemia and response to treatment in diabetes. Lancet 2003;362:1275-81.
4. Pearson ER, Liddle WG, Shepherd M, Corrall RJ, Hattersley AT. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1α gene mutations: evidence for pharmacogenetics in diabetes. Diabet Med 2000;17:543-5.
5. Tuomi T, Honkanen EH, Isomaa B, Sarelin L, Groop LC. Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3. Diabetes Care 2006;29:189-94.